Dasatinib, high-dose imatinib and nilotinib for the treatment of imatinib-resistant chronic myeloid leukaemia: a systematic review and economic evaluation.
about
Nilotinib versus dasatinib as second-line therapy in patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase who are resistant or intolerant to imatinib: a cost-effectiveness analysis based on real-world data.Effectiveness and Cost-Effectiveness of Sequential Treatment of Patients with Chronic Myeloid Leukemia in the United States: A Decision AnalysisEstimated generic prices of cancer medicines deemed cost-ineffective in England: a cost estimation analysis.Systematic assessment of decision-analytic models for chronic myeloid leukemia.Current perspectives on the therapeutic aspects of chronic myelogenous leukemia.Update on emerging treatments for chronic myeloid leukemia.Estimation of the prevalence and direct medical costs of chronic myeloid leukemia in the I.R. of Iran in the era of tyrosine kinase inhibitors.Cost-effectiveness of kinase inhibitors for hematologic malignancies: a systematic and critical review.Excellent outcomes of 2G-TKI therapy after imatinib failure in chronic phase CML patients.
P2860
Q31142213-4F3F8E59-486F-474A-85F2-BF014BF53BDDQ36400944-B7247550-5005-4A03-971F-250429117164Q37598156-A1021DA0-9243-4419-ADE2-05E6DB8DFE57Q38175353-B5C4543F-01FC-4D01-ACB5-5015CEF2E2F5Q38243861-C8D51D48-C05B-40D5-B57C-00BB6E85B683Q38397515-94093676-84DE-4F6F-82EC-2EA855810EF3Q39909602-10D56FB4-B55A-439F-A1B0-116CDB1A6141Q47968789-C302B1DE-E2E9-4035-834A-D12F43AB39A4Q54119186-1937D518-748B-4AD5-BE1C-DFB85F536B9B
P2860
Dasatinib, high-dose imatinib and nilotinib for the treatment of imatinib-resistant chronic myeloid leukaemia: a systematic review and economic evaluation.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Dasatinib, high-dose imatinib ...... eview and economic evaluation.
@ast
Dasatinib, high-dose imatinib ...... eview and economic evaluation.
@en
Dasatinib, high-dose imatinib ...... eview and economic evaluation.
@nl
type
label
Dasatinib, high-dose imatinib ...... eview and economic evaluation.
@ast
Dasatinib, high-dose imatinib ...... eview and economic evaluation.
@en
Dasatinib, high-dose imatinib ...... eview and economic evaluation.
@nl
prefLabel
Dasatinib, high-dose imatinib ...... eview and economic evaluation.
@ast
Dasatinib, high-dose imatinib ...... eview and economic evaluation.
@en
Dasatinib, high-dose imatinib ...... eview and economic evaluation.
@nl
P2093
P356
P1476
Dasatinib, high-dose imatinib ...... eview and economic evaluation.
@en
P2093
P304
iii-xiii, 1-137
P356
10.3310/HTA16230
P577
2012-01-01T00:00:00Z